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Empirical use of countless remedies for psori-
asis over the centuries has sorted out a relatively
small number of drugs or agents that are recog-
nized as having the worthwhile property of
favorably affecting the disease. The most com-
monly utilized of these include ultraviolet light,
X-radiation, derivatives of coal tar, and com-
pounds of mercury and arsenic. The reason for
the effectiveness of these agents is unknown, al-
though various explanations have been conjec-
tured. A rather popular and credible belief has
been that the agents affect the lesion of psoriasis
by virtue of their poisonous nature, inhibiting
epidermal hyperplasia because of their general
toxicity to cells. The observation of Gubner (1),
later verified in many patients by Rees and
Bennett (2), that aminopterin, a folie acid
antagonist having anti-tumor properties, can
cause clinical clearing of the cutaneous eruption
of psoriasis seems to be compatible with this
belief. One test of the hypothesis, however,
would be to determine whether the histologic and
cytologic changes occurring in the epidermis
during healing of the lesion of psoriasis are similar
following the different therapeutically effective
agents.
Burks and Montgomery (3) studied the histo-
logic changes of psoriasis in patients treated with
topically-applied tar and ultraviolet light in
specimens removed on the lOth—l4th day of this
treatment. In these specimens a stratum granulo-
sum was present; the stratum eorneum was nor-
mal or slightly thickened, with diminished
parakeratosis.
Following the report of Sullivan and King (4)
which called attention to the merits of topically-
applied podophyllum resin in affecting the hyper-
plastic lesions of condylomata aecuminata and
verrucae vulgares, Ferrari (5) reported that
podophyllin, as well as colehieine, could bene-
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ficially influence the lesion of psoriasis. King and
Sullivan (6) made fundamental observations on
epidermal changes in normal skin, condyloma
aeeuminatum, and verruca vulgaris that occurred
in response to podophyllin and also noted that
similar changes occurred following topical appli-
cation of colehieine. Twenty-four hours following
the application of these drugs characteristic
nuclear damage (arrested mitoses and dispersion
of ehromatin particles) of Malpighian cells was
present and granules were found in cells of the
upper Malpighian layer. At 7 days a prominent,
broad granular layer was present. King (7) later
described in detail epidermal changes in normal
skin of mice following podophyllin and called
attention to excessive production of tonofibrils by
the cytoplasm of cells whose nuclei had been
damaged by the drug.
Normal and abnormal growth of tissue present
challenging problems to biology and medicine.
The epidermis is a tissue particularly exploitable
for study of these problems because it is accessi-
ble for experimental manipulative procedures.
Furthermore, because of the unidirectional mi-
gration of its cells during their life span, suc-
ceeding generations of cells and products
synthesized can be studied for changes resulting
from such procedures.
The purpose of the present work was to study
the effects of agents generally classified as poisons
on epidermal hyperplasia of pseriasis, and to
compare these with alterations following some
newer chemotherapeutic anti-tumor agents
having both known and unknown modes of bio-
chemical action. The study was not undertaken
as a therapeutic trial and was not designed to
evaluate any of the agents used in regard to
effectiveness, or indications for use, in the clinical
management of psoriasis.
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MATERIALS AND METHODS
Drugs were selected for systemic administra-
tion to patients with psoriasis because of the
ability of these drugs or their analogues to inter-
fere with the growth of hair (8). Patients were
selected for systemic therapy from the following
358 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
groups: adult males with severe, disabling
psoriasis; women beyond the menopause with
severe psoriasis; and patients with a 2—3 year
history of repeated courses of aminopterin ther-
apy referred for general evaluation, who were
given one additional course of aminopterin while
under our observation. A total of eighteen pa-
tients, 30—76 years of age, participated in this
study. Seven received one or more drugs systemi-
cally. Sixteen were tested with topically-applied
drugs.
The following drugs, with the exception of
aminopterin, were administered in single intra-
venous doses: methotrexate* (6 patients), 0.5
mgm.—5 mgm./Kg.; actinomyein Dt (3 patients),
25 micrograms/Kg.; 5-fluorouracilt (3 patients)
5, 7.5 and 10 mgm./Kg.; colehicine (1 patient),
weekly intravenous doses, the largest of which was
5 mgm. Aminopterin was given to one patient in a
dosage of 0.5 mgm. orally twice daily for 6 days;
a second patient received 0.5 mgm. once daily for
12 days.
The following examinations were carried out
prior to therapy: white blood cell count, hemo-
globin, platelet count, blood urea nitrogen, liver
function tests and skin biopsy. Spermatozoa
counts were determined in two patients given
aminopterin and in two patients given methotrex-
ate. All procedures were repeated during and
after therapy, with the exception of blood urea
nitrogen determinations and liver function tests.
Scalp hair roots were examined during therapy for
presence of dysplasia, by a previously described
technique (11).
Topical therapy was confined to localized areas
of skin on the trunk, 2 x 2 inches in size or larger.
Initially in each case the agent, in an appropriate
solvent or vehicle (70% alcohol, water or Aqua-
phor®), was applied under an occlusive dressing
for 18—24 hours. Subsequently, the agents were
applied topically in different vehicles or solvents,
on involved and uninvolved skin, for varying
lengths of time.
The following agents were applied topically:
methotrexate (9 patients), 5—50 mgm. in 2 cc
1120, and as the pure powder; 5-fluorouracil (4
* 4-amino-N'°-methyl pteroylglutamie acid, afolie acid antagonist similar to aminopterin in
chemical structure and anti-tumor properties.
t A compound having anti-bacterial and anti-tumor properties, isolated from cultures of
Streptomyees parvallus. Its mechanism of action is
unexplained. For bibliography see Reference (9).
t A pyrimidine analogue with a broad spectrum
of activity against experimental tumors. Its action
is considered to be due to inhibiting the 5-methyl-
ation of pyrimidines (10).
patients), 10 mgm./2 cc 1120); aetinomycin D (4
patients), 40 micrograms/2 cc 1120; nitrogen
mustard (3 patients), .04—0.5 mgm./2 cc 1120;
mercury (6 patients), 20% in aquaphor; podophyl-
lum resin (15 patients), 0.5—1% in 70—95% alcohol,
petrolatum, and tincture of benzoin; eolcemide (3
patients), 0.5—1.0 mgm./2 cc 70% alcohol; tn-
methyl colchieinic acid (3 patients), 1 mgm./2 cc
70% alcohol; colchieine (5 patients), 0.1—3.6 mgm./
2 cc 70—90% alcohol; undiluted liquor carbonis
detergens (1 patient); 100% deuterium oxide (2
patients); 6-mereaptopurine (4 patients), 10
mgm./2 cc 1120; triethylene thiophosphoramide
0.5 mgm./2 cc 1120.
RE5ULT5
Clinical changes following drugs administered
systemically. During the first week following a
single intravenous dose of methotrexate, 5-fluoro-
uracil, or actinomycin D the skin involved with
psoriasis in most instances became somewhat
more erythematous than usual, particularly at
the margins of the lesions. In some patients a
marked decrease in scales occurred during this
time despite the more florid appearance of the
underlying skin. At about the end of the first
week the involved areas were less erythematous
than before the day of therapy and marked
reduction in scales was evident. In all cases le-
sions on the head and upper trunk were first to
improve; last to improve were lesions on the
forearms and lower extremities. In some patients
improvement continued for varying lengths of
time up to about three weeks (Figs. 1 & 2). In
no ease did all lesions disappear from the skin
without further therapy, either topical or sys-
temic. In most patients lesions ceased to improve
within two weeks of the day of drug administra-
tion, relapsing thereafter to their pretreatment
state.
In the one patient who received weekly intra-
venous doses of colchicine, involved areas of skin
appeared less erythematous and scaly only after
five weeks of therapy. The weekly dose had been
increased to 5.0 mgms. by that time and although
no signs of either clinical or hematological toxic-
ity were detectable in the patient, the dose was
lowered to 3.0 mgm. and was given twice weekly
instead of weekly. The drug was continued at the
latter dosage for two additional weeks and then
discontinued, no further improvement of the
skin having occurred.
The clinical response of psoriasis was not
specifically followed in the two patients receiving
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aminopterin in daily oral doses. These patients
had been referred primarily for study of possible
sequelae secondary to taking this drug for two
and three years previously and were clinically
observed only at occasional intervals when they
reported for test procedures performed to evalu-
ate systemic effects of the drug.
A number of signs of acute toxicity were ob-
served in pTtients receiving single doses of metho-
trexate, 5-fluorouracil, and actinomycin D. The
signs included those indicative of bone marrow
depression (lowering of the counts of white blood
cells and platelets in the peripheral blood), signs
of varying degrees of injury to the alimentary
canal (nausea and/or ulcerations of the oral
mucous membrane), and disturbance of hair
growth (dysplasia of the roots of anagen hairs
with or without hair loss). Evidence of depression
of spermatogenesis was found in four patients
studied for this. Two of these patients received
methotrexate, the other two received aminop-
term. The range of depression of spermatozoa
counts (sperm/cc.) ranged from 49—90%; the
range of depression of total spermatozoa per
specimen varied from 63% to 97%. The lowered
counts were detected 12—14 days from the day a
single intravenous dose of methotrexate had been
given, or from the first day of therapy with daily
oral aminopterin. The time interval for the counts
to return to normal was not determined. How-
ever, it is apparent that spermatogenesis is not
permanently depressed since in the two patients
who had taken repeated courses of aminopterin
for 2 and 3 years previously the pretreatment
control examinations revealed normal sperma-
tozoa counts, both in total spermatozoa per
specimen and in number per cc.
Clinical changes following topical application of
drugs. Marked gross changes in lesions of psoriasis
were evident following occlusive application of
podophyllin, colchicine, mercury, nitrogen mus-
tard, and liquor carbonis detergens. On the
fourth day following the day of appication the
localized area of skin where each drug had been
applied was, in most instances, free of scales
(Fig. 3); erythema was either absent at this time
or was only minimally visible. These changes
were most pronounced when the drugs were used
in the higher concentrations, although in a few
patients, all of whom had inveterate localized
patches of psoriasis, the treated areas did not
develop the changes towa.rd normal until as long
as two weeks later. The areas remained as islands
of clinically normal skin, located within a patch
of involved skin, for variable lengths of time
thereafter, from one week to approximately six
weeks (Fig. 4). They were then re-involved with
psoriasis by a process in which the cleared areas
of skin were invaded by psoriasis from the
periphery.
With the exception of colcemide and trimethyl
colchicinic acid, both of which caused only
questionable improvement of psoriatic skin
within one week of the day of application, none
of the other compounds tested topically had any
observable effects on either lesions of psoriasis or
on uninvolved skin.
Histologic changes. The healing process in
psoriatic skin that occurred following each of the
several drugs found to be clinically effective was
basically similar in certain salient histologic
features in all instances, although differences
could be found to characterize the action of some
drugs.
Twenty-four hours following occlusive applica-
tion of either podophyllin or coichicine numerous
cells in the lower two-thirds of the Malpighian
layer showed various degrees of damage. Most
obvious were cells with a markedly enlarged
nucleus in which chromatin particles were either
in clumps or scattered in rather random disorder
(Fig. 5). In the uppermost level of the Malpighian
layer was a zone in which the cells were quite
distinct from those of the deeper Malpighian
layer (Fig. 6). These cells were large and their
walls appeared thick. Their nuclei were pyknotic.
Numerous fine granules, which were morphologi-
cally indistinguishable from keratohyaline gran-
ules, studded a pale-staining cytoplasm. Such
cells constituted a layer which was up to ten cells
in thickness. The stratum corneum, at this time,
was parakeratotic, in no way different from that
of untreated control specimens.
Specimens removed 48 hours after the applica-
tion of podophyllin or coichicine had changes
similar to those found in the 24-hour specimens,
although somewhat less in degree, and in addition
contained other alterations later found to be
maximal in the 96-hour specimens. The transi-
tional nature of the changes in the 48-hour
specimens becomes apparent when comparison
is made with the histologic findings in the 96-hour
specimens.
The state of the epidermis 96 hours following
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podophyllin or colehieine was distinctive. The
cells of the upper Malpighian layer now were
flattened and made up a stratum granulosum
that was up to 10—12 cell layers in thickness (Figs.
7, 8). Except for the extreme thickness of this
layer, the cells and the granules contained therein
appeared normal both in regard to morphology
and staining properties. A thin stratum eorneum,
appearing to be normally keratinized, was present
immediately distal to the thickened granular
layer. Associated with this change was what may
be interpreted as a sign of an exaggerated process
of keratinization; in the upper portions of the
Malpighian layer was a dense network of
thickened tonofibrils with particularly prominent
nodules of Bizzozero in the intercellular bridges
(Fig. 9). The epidermis, although somewhat
diminished in thickness as measured through an
ocular micrometer, retained its acanthotie ap-
pearance at this time.
The above-described changes that took place
in psoriatie epidermis in response to topically
applied podophyllin and eolehieine were also
found in the epidermis of uninvolved skin of
three patients tested. The magnitude of the
changes was reduced, however.
Histologic alterations in epidermis affected
with psoriasis can be correlated with the gross
healing of lesions observed clinically. The action
of these drugs appears to be a direct inhibition of
epidermal hyperplasia, by arrest of mitosis, while
allowing the process of keratinization to continue
unimpeded in these otherwise damaged cells.
Changes occurring in psoriatie epidermis fol-
lowing topical application of mercury, nitrogen
mustard, and liquor carbonis deter gens were, at
96 hours, identical to those that were found 96
hours after application of podophyllin and
eolehieine. That is, clinical recovery of the lesion
at this time was associated with a markedly
thickened granular layer and a dense network of
tonofibrils in the Malpighian layer (Fig. 10). No
evidence of disturbed mitosis or nuclear damage
was found at 24 hours or 48 hours following appli-
cation of these drugs. However, very few mitotie
figures were found in the epidermal cells at these
times, suggesting that epidermal hyperplasia
had been inhibited, but by a mechanism different
from that with either podophyllin or eolehieine.
Histologic changes in psoriatie epidermis
following systemic administration of methotrexate
and 5-fluorourocil (biopsy specimens not oh-
tamed sufficiently early following aetinomyein D)
were indistinguishable from those following
topical application of mercury, nitrogen mustard
or liquor earbonis detergens. Because clinical
improvement of lesions of psoriasis was most
evident approximately one week following a
single dose of these drugs, most biopsy specimens
were obtained at this time and several days there-
after. In all specimens removed at these times
the epidermis appeared to be quite normal except
that it was somewhat acanthotie. Specimens
were obtained earlier in two patients, one patient
having received methotrexate and the other
5-fluorouraeil. Although lesions showed little or
no evidence of clinical improvement at these
earlier times distinct histologic changes were
present. Twenty-four hours following the time
when methotrexate was given the epidermis did
not contain a single cell in mitotie division. At 48
hours a few cells in mitosis could be found and at
this time keratohyaline granules could be iden-
tified in cells of the upper Malpighian layer.
Cells containing such granules constituted a zone
6—7 cell layers in thickness in the uppermost
portion of the Malpighian layer. in a specimen
obtained three days following 5-fluorouraeil, and
in another taken 5 days after administration of
methotrexate, a well-formed granular layer, 5—6
cell diameters in thickness, had already formed
(Fig. ii). A network of prominent tonofibrils
was present in these specimens and, although the
outermost stratum eorneum was parakeratotie, a
thin zone of normal-appearing stratum eorneum
lay immediately distal to the stratum granulo-
sum.
DISCUSSION
Data from these studies indicate that the lesion
of psoriasis is a result of hyperplasia of the
epidermis in which cellular reproduction proceeds
at a rate sufficiently rapid that maturation of
epidermal cells and synthesis of tonofibrils is not
completed, formation of a stratum granulosum
does not occur, and the biologic and chemical
processes of normal keratinization are not
achieved. The remedial effects on psoriasis that
are obtainable with topically-applied or systemi-
cally-administered agents, of the kind employed
in this study, would seem to be due to their
arresting or inhibiting the accelerated rate of
epidermal hyperplasia, allowing adequate time
and/or diversion of energy within cells for
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morphologic changes and metabolic processes to
occur normally.
It is clear that inhibition of epidermal hyper-
plasia is not dependent upon a single pathway or
site of action common to all drugs causing this
inhibition, since these drugs affect epidermal cells
in several different ways. Further understanding
of processes invclved in maturation of epidermal
cells and their synthesis of keratin may be
derived from a consideration of the modes of
action and morphologic effects of different chemi-
cal agents on the epidermis.
The effect of podophyllin and colchicine on
cells of the Malpighian layer, and the further
response of cells while under this effect, are
particularly interesting and informative. Nuclear
damage, identified as arrested mitoses and disin-
tegration of nuclear material, is the primary
effect of these drugs. When cells arc so affected,
however, production of tonofibrils continues.
These phenomena occur in the epidermis of the
mouse following application of podophyllin and
have been identified and acutely described by
King (7), who also pointedly emphasized that in
epidermal cells affected by podophyllin "cyto-
plasmic activity concerned with fibril production
continues unabated while the nucleus remains in
a state of suspended mitosis". Since available
evidence indicates that tonofibrils are keratinous
in nature (12, 13, 14, 15) it seems rather impor-
tant to recognize the fact that synthesis of keratin
(or its precursor(s)) is a specialized function of the
cytoplasm of epidermal cells and appears to be
independent of the nucleus. Such a situation is
compatible with a concept of cellular functions
proposed by Rusch (16): ". . . all cellular func-
tions are divided into two chief categories: one,
the function of reduplication, and two, all other
special functions not primarily concerned with
cellular multiplication". Tonofibrils may be
abundantly produced in mitotically arrested cells
because more time is allowed for cytoplasmic
production of tonoflbrils before the cells reach the
epidermal surface. On the other hand, tonofibrils
may be produced so abundantly because addi-
tional cellular energy is now available for their
synthesis, energy which would have been utilized
for cellular division but now diverted because of
nuclear damage and mitotic arrest. The latter
possibility is compatible with the fore-mentioned
concept of Rusch, which further states, "In
addition to being mutually dependent, the various
functions must also be recognized as mutually
competitive with respect to the cellular nutrients
required for their synthesis". Clinical clearing of
the lesion of psoriasis following the action of
podophylliri or colchicine on the epidermis may
therefore result, at least in part, from a quantita-
tive increase in keratin synthesis by each cell.
Although the modes of action of those chemical
agents used in the present study which effectively
restored the lesion of psoriasis toward normal
may be different for each agent, the essential
epidermal changes produced by each are similar.
That is, all agents appear to inhibit cellular
reduplication since within 24 hours following
their use mitoses were either arrested, totally
absent, or decreased in number. Regardless of the
means by which cellular division had been re-
strained a marked increase of tonofibrils occurred
and was associated with other morphological
changes within the epidermis that indicated
normal keratinization had resumed.
Topical application of methotrexate, 5-fluoro-
uracil and actinomycin-D failed to influence the
lesion of psoriasis. Repeated topical testings of
methotrexate were made including its application
as a pure powder, application in solutions at
various levels of alkaline and acid pH, and
application onto lesions after the stratum cor-
neum was removed by means of cellulose tape. It
is known that the drug can penetrate psoriatic
epidermis since it has been detected in the urine
following its topical application onto lesions
(17). Failure of it to locally affect psoriasis there-
fore suggests that its pharmacologic action
requires initiation at a distant systemic site.
How many of the newer chemotherapeutic
drugs that are used systemically to treat cancer
might be found to affect psoriasis is unknown.
Rees and Bennett (2) reported that they found
both 6-mereaptopurine and Daraprim® (2,4
diamino-5-p-chloropteroyl-6-ethyl-pyrimidine) to
be ineffective. Blank (19) has observed psoriasis
to improve in a patient with leukemia who re-
ceived Myleran® (1,4 ,-dimethane sulfonoxy
butane). Methotrexate, 5-fluorouracil and actino-
mycin-D were purposely selected for our study
because they were known to interfere markedly
with the growth of hair (8), an epidermal tissue.
It seems judicious to make some comment re-
garding the advisability of using anti-tumor
chemotherapeutie agents in the general manage-
ment of psoriasis. The serious acute toxic effects
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that these agents can cause are well recognized.
Possible carcinogenic properties of each for man
have not been evaluated, nor does it seem that
this can be done until a considerable period of
time has elapsed. Until the necessary clinical data
on each agent are obtained their general use in
the treatment of psoriasis cannot be advocated.
The ehemotherapeutic agents are helpful tools
for investigating the nature of the lesion of
psoriasis and biologic processes of the epidermis.
Data from such studies may be useful in a search
for the cause and specific therapy of psoriasis, as
well as contribute information to better under-
stand malignant hyperplasia.
SUMMARY
1. Morphologic and physiological changes in
psoriasis were studied by means of topically
applied and systemically administered chemical
agents. Clinical clearing of the lesion of psoriasis
occurred following intravenous administration
of methotrexate, 5-fluorouracil and actinomyein
D, and following occlusive topical application
of podophyllin, colehicine, mercury, nitrogen
mustard, and liquor earbonis detergens.
2. The clinical effects on the lesion of psoriasis
of both topically and systemically used therapeu-
tic agents were directly correlated with depressed
cellular reduplication of the epidermis. With
systemically used agents depression of cellular
reduplication in the epidermis paralleled a similar
depression in other tissues of the body.
3. Independent functions of the nucleus and
cytoplasm of epidermal cells were recognizable.
The initial histological effect of the various
agents on epidermal cells was nuclear damage,
i.e. inhibition or arrest of mitosis. Cytoplasmic
activity appeared undisturbed, however, since
formation of tonofibrils and keratohyaline gran-
ules continued.
4. The morbid state of the epidermis in
psoriasis can be defined in terms of excessive
mitotic activity and incomplete cellular matura-
tion.
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DISCUSSION
DR. JACOB H. SWARTz (Boston, Mass.): In
1945 I reported in the New England Journal of
Medicine on the interrelation of Streptococcus
fecGtis and psoriasis. At that time I noticed that
intracutaneous injections of Streptococcus fecelis
obtained from stools of psoriatic patients
produced a psoriatie papule clinically indistin-
guishable from typical psoriasis, on the normal
skin of patients with psoriasis. Control studies
with typhoid vaccine, staphylococcus toxoid and
normal saline solution did not produce a similar
phenomenon. The usual local reaction was oh-
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tamed with injections of autogenous vaccine of
strept. fecalis in non-psoriatic subjects. As a
result of such findings I began to treat psoriatic
patients with Streptococcus fecalis vaccine. Not
being familiar with the disage, I found that a
number of those so treated grew worse and a
few developed exfoliative dermatitis. In four
patients I noted the development of psoriatic
arthropathy which these patients did not have
before treatment.
Dr. Peck reported to me a similar experience. A
few patients did improve as a result of such
treatment. Time does not permit a discussion of
dosage.
I then began to use mandellic acid enemas,
since mandellic acid has been used effectively by
urologists in infections of the bladder caused by
this microorganism. I chose enemas because of the
greater contact of the chemotherapeutic agent
with the microorganism.
The results have been gratifying in a fair
number of patients. Coincidental with improve-
ment there was a decrease in the colony count of
Streptococcus fecalis in the stools. The local treat-
ment was limited to petrolatum. These patients
were treated during exacerbations.
I present this as another mode of therapy which
has no serious sequelae. It is, 1 believe, more than
just nonspecific therapy.
Histochemical studies of the upper epidermis
before and during treatment have not been done.
Such studies may be worth while.
Amiriopterin is an antagonist to folic acid
which in turn is essential for the metabolism of
Streptococcus fecalis. The good effect of amino-
pterin may also therefore be due to its deterrent
effect on Streptococcus fecalis.
DR. ERWIN P. ZEISSILER (Winnetka, Ill.): I
should like to congratulate the gentlemen from
the National Cancer Institute on the results they
have had in psoriasis.
One would judge from the list of chemothera-
peutic agents presented to us here today that in
treating psoriasis that the disease might have
been a leukemia. These same compounds all have
antileukemic properties. They are powerful
protoplasmic poisons and their use must be
carefully watched.
I would also like to say that in the treatment
of psoriasis there is no substitute for sun light.
Whether you use ultraviolet light of x-ray, or
other actinic agents, the results will not be as good
as when the entire body is exposed to the sun. I
have always in my practice adhered to the
principle of using sunlight where possible and I
sent my patients to California or Florida, or
Arizona for this purpose and I believe also that
Dr. Goeckerman got along very nicely without
the use of colchicine or any types of steroids in the
treatment of psoriasis in which he advocated the
use of coal tar and ultraviolet exposures ac-
cording to a regular scheme. As intimated by my
remarks I believe you are playing with fire in
using these drugs except in exceptional cases
where their use may be justified.
DR. RUDOLF BAER (New York, N.Y.): I would
like to ask Dr. Van Scott whether he has any
data as to how long the depression of the white
count lasts after aminopterin has been discon-
tinued? This question is of considerable impor-
tance because if the depression of the white count
disappears within a few days one will not find
any depression when doing a blood count a week
after the drug has been stopped and thus one
may overlook this undesirable effect on the
hemopoietic system
Another important practical question was
raised the other day when a small group of that
vanishing species—the clinician—discussed the
effect of aminopterin. Dr. Osborne stated—and
I hope that I am quoting him correctly—that
there is a greater tendency to depression of the
white count in patients with psoriasis over 60
years of age treated with aminopterin than
among younger persons and that therefore these
are the patients in whom one has to be especially
careful regarding hematologic side effects. I
wonder whether Dr. Van Scott has any informa-
tion on this point.
DR. WILLiAM B. REED (Burbank, Calif.): I
enjoyed the discussion very much. I would like to
know whether Dr. Van Scott treated any patients
with psoriatic arthritis with the chemotherapeu-
tic agents? Did the treatment have any effect on
the arthritis?
DR. FREDERICK D. MALKINSON (Chicago, Ill.):
We too applied colchicine locally in the treatment
of psoriasis with temporarily good results, using
the same concentration that Dr. Van Scott used,
0.1 per cent. With continued treatment there is
quite a risk of irritation of course.
Another important factor in the local applica-
tion of colchicine is that this compound is an
alkaloid which presumably may be very well
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absorbed through the skin. To date no quantita-
tive studies of percutaneous absorption of
coichicine have been done. Widespread applica-
tion of this material to the skin, then, is not
indicated.
In one of our patients who had had long
standing ps@riasis and both rheumatoid and
psoratic arthritis we saw some definite improve-
ment in joint symptoms with the usc of colehicine.
Apparently this again confirms Gubner's original
observation that antimitotic agents may be
beneficial for joint involvement also.
Da. EUGENE J. VAN SCOTT (in closing): The
observations of Dr. Swartz are interesting but
puzzling to mc and I have no immediate expla-
nation for them.
Dr. Zeissler, I hope that you have not mis-
understood the objectives of this work. One of
the reasons we undertook it was that it particu-
larly related to the reservations you have ex-
pressed.
Aminopterin is being used in psoriasis and it is
time we defined what these agents do, their
immediate dangers and possible sequelae. We
have wondered, for instance, whether the anti-
metabolites are carcinogenic. To date aminop-
term has not been shown to be carcinogenic.
This does not indicate that it is not, but it has
not been demonstrated. Dietary starvation can
beneficially influence psoriasis. Perhaps the
effects on psoriasis that results from blocking
the utilization of folie acid may be a chemical
starvation similar to dietary starvation. Since
this is unknown, however, the usc of folie acid
antagonists and other antimctabolites cannot be
advocated for routine therapy of psoriasis. We
have further used these agents experimentally in
a few patients because we are interested in
cancer. Psoriasis is a disease characterized by
benign hyperplasia of cells. Because of this
hyperplastie activity of psoriasis we have used it
as a model to determine the biological effects of
agents on the behavior of rapidly dividing cells.
It seems interesting and important, for example,
to single out a cytoplasmic function that is rela-
tively independent of nuclear function, as the
results of these studies indicate. I can only agree,
however, that the therapeutic use of new agents
in humans must be approached with caution.
In answer to Dr. Baer's question regarding
depression of the white cell count, following the
doses of the agents used, the white cell count
returned to normal within a two week period.
But this of course is proportionate to the dose. If
the dose is large enough the white count would be
irreversibly depressed, as would be a number of
vital functions. I think you must be equally as
careful with the young, middle aged and old
aged persons regarding the depression of the
white count.
Lastly, we have treated three patients with
psoriasis who also had arthritis and have seen no
definitive changes in the arthritis.
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FIG. 1. Generalized psoriasis untreated. Thirty-five year-old man.
FIG. 2. Same patient as in Fig. 1, ten days following single TV. injection of methotrexate.
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FIG. 3. Gross changes in psoriasis 4 days following occlusive application of coichicine on left, podo-
phyllin on right. Back of 56-year-old man.
FIG. 4. Gross changes in psoriasis on abdomen of 35-year-old man 1 month following occlusive applica-
tion of podophyllin. Alcoholic solution of the drug was applied in sponge rubber, cut in the form of letters
of the alphabet.
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FIG. 5. Photomicrograph of Malpighian layer of epidermis from lesion of psoriasis, 24 hours following
topical application of podophyllin. Characteristic enlarged nuclei with scattered or clumped chromatin
granules are present. Gomori triehrome stain. X68O.
FIG. 6. Cells of upper Malpighian layer in psoriasis 24 hours following topical application of podo
phyllin. Note keratohyaline granules in cytoplasm. Gomori trichrome stain. X530.
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FIG. 7. Epidermis of psoriasis 4 days following colchieine topically. Stratum granulosum is much
thicker than normal. Gomori trichrome stain. X380.
FIG. S. Epidermis of psoriasis 4 days following podophyllin topically. X500.
FIG. 9. Excessive tonofibrils in epidermis of psoriasis 4 days following colchicine topically. Gomori
trichrome stain. X2000.
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FIG. 10. Thickened granular layer in epidermis of psoriasis 4 days following occlusive topical applica-
tion of liquor carbonis detergens. X380.
Fxo. 11. Similar thickening of granular layer in epidermis of psoriasis 3 days following single intra-
venous dose of 5-fluorouracil, X380.
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